Integra Lifesciences Holdings Corp

詳細情報 Integra Lifesciences Holdings Corp 企業名

Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, bone grafts, and nerve and tendon repair products.

企業情報

企業コードIART

会社名Integra Lifesciences Holdings Corp

上場日Aug 16, 1995

最高経営責任者「CEO」Ms. Mojdeh Poul

従業員数4396

証券種類Ordinary Share

決算期末Aug 16

本社所在地1100 Campus Road

都市PRINCETON

証券取引所NASDAQ Global Select Consolidated

国United States of America

郵便番号08540

電話番号16092750500

ウェブサイトhttps://www.integralife.com/

企業コードIART

上場日Aug 16, 1995

最高経営責任者「CEO」Ms. Mojdeh Poul

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Stuart M. Essig, Ph.D.

Executive Chairman of the Board

1.59M

-11.20%

Mr. Christian S. (Chris) Schade

Independent Director

90.03K

+41.78%

Dr. Keith Bradley, Ph.D.

Independent Director

89.14K

+27.45%

Mr. Michael J. Mcbreen

Executive Vice President, President - Codman Specialty Surgical

70.34K

+25.21%

Ms. Lea Daniels Knight

Chief Financial Officer, Executive Vice President

58.58K

-4.19%

Mr. Jeffrey Mosebrook

Senior Vice President - Finance, Principal Accounting Officer

35.79K

-10.69%

Mr. Harvinder Singh

Executive Vice President, President - International Business

13.25K

+1024.00%

Ms. Mojdeh Poul

President, Chief Executive Officer, Director

--

Ms. Shaundra D. Clay

Independent Director

--

Mr. Chris Ward

IR Contact Officer

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Stuart M. Essig, Ph.D.

Executive Chairman of the Board

1.59M

-11.20%

Mr. Christian S. (Chris) Schade

Independent Director

90.03K

+41.78%

Dr. Keith Bradley, Ph.D.

Independent Director

89.14K

+27.45%

Mr. Michael J. Mcbreen

Executive Vice President, President - Codman Specialty Surgical

70.34K

+25.21%

Ms. Lea Daniels Knight

Chief Financial Officer, Executive Vice President

58.58K

-4.19%

Mr. Jeffrey Mosebrook

Senior Vice President - Finance, Principal Accounting Officer

35.79K

-10.69%

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Neurosurgery

190.91M

49.89%

Wound Reconstruction and Care

74.78M

19.54%

Instruments

50.95M

13.31%

ENT

38.80M

10.14%

Private Label

27.21M

7.11%

地域別USD

会社名

収益

比率

United States

282.22M

73.75%

Asia Pacific

45.10M

11.79%

Europe

35.33M

9.23%

Rest of World

20.00M

5.23%

事業別

地域別

事業別USD

会社名

収益

比率

Neurosurgery

190.91M

49.89%

Wound Reconstruction and Care

74.78M

19.54%

Instruments

50.95M

13.31%

ENT

38.80M

10.14%

Private Label

27.21M

7.11%

株主

更新時刻: Fri, Aug 15

株主統計

種類

株主統計

比率

BlackRock Institutional Trust Company, N.A.

12.11%

TRU ST Partnership, L.P.

10.93%

The Vanguard Group, Inc.

9.63%

Rubric Capital Management LP

9.44%

Fuller & Thaler Asset Management Inc.

5.00%

他の

52.90%

株主統計

比率

BlackRock Institutional Trust Company, N.A.

12.11%

TRU ST Partnership, L.P.

10.93%

The Vanguard Group, Inc.

9.63%

Rubric Capital Management LP

9.44%

Fuller & Thaler Asset Management Inc.

5.00%

他の

52.90%

種類

株主統計

比率

Investment Advisor

37.14%

Investment Advisor/Hedge Fund

35.40%

Hedge Fund

18.02%

Corporation

10.93%

Research Firm

3.23%

Individual Investor

3.18%

Pension Fund

1.43%

Bank and Trust

0.44%

Sovereign Wealth Fund

0.04%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

600

89.38M

114.72%

-18.72M

2025Q1

635

87.01M

111.97%

-18.30M

2024Q4

636

81.93M

106.10%

-20.27M

2024Q3

638

82.93M

106.93%

-12.58M

2024Q2

628

84.82M

107.92%

-1.75M

2024Q1

613

79.36M

101.18%

-3.69M

2023Q4

597

79.81M

101.26%

-5.74M

2023Q3

592

81.88M

100.31%

-3.94M

2023Q2

587

82.30M

100.29%

-6.57M

2023Q1

579

85.87M

104.63%

-5.43M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

BlackRock Institutional Trust Company, N.A.

9.75M

12.55%

-341.75K

-3.38%

Mar 31, 2025

TRU ST Partnership, L.P.

8.52M

10.96%

--

Feb 28, 2025

The Vanguard Group, Inc.

7.47M

9.61%

-66.65K

-0.88%

Mar 31, 2025

Rubric Capital Management LP

4.64M

5.98%

+2.03M

+77.35%

Mar 31, 2025

Fuller & Thaler Asset Management Inc.

3.92M

5.05%

-9.76K

-0.25%

Mar 31, 2025

Invesco Advisers, Inc.

3.13M

4.02%

+1.36M

+77.42%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

2.58M

3.32%

+212.16K

+8.95%

Mar 31, 2025

State Street Global Advisors (US)

2.75M

3.54%

-105.48K

-3.70%

Mar 31, 2025

Boston Management and Research

2.74M

3.53%

--

Mar 31, 2025

Paradigm Capital Management, Inc.

1.39M

1.78%

-45.90K

-3.21%

Mar 31, 2025

詳細を見る

15.380USD

Integra Lifesciences Holdings Corp

15.380

概要

企業名

金融

分析